Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients

The costly and burdensome nature of the current follow-up methods in non-muscle-invasive bladder cancer (NMIBC) drives the development of new methods that may alternate with regular cystoscopy and urine cytology. The Uromonitor-V2(®) is a new urine-based assay in the detection of hotspot mutations i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieverink, Caroline A., Batista, Rui P. M., Prazeres, Hugo J. M., Vinagre, João, Sampaio, Cristina, Leão, Ricardo R., Máximo, Valdemar, Witjes, J. Alfred, Soares, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599569/
https://www.ncbi.nlm.nih.gov/pubmed/32987933
http://dx.doi.org/10.3390/diagnostics10100745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599569/
https://www.ncbi.nlm.nih.gov/pubmed/32987933
http://dx.doi.org/10.3390/diagnostics10100745

Ejemplares similares